-
1
-
-
84855792427
-
Cancer statistics, 2012
-
2-s2.0-84855792427 10.3322/caac.20138
-
Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA Cancer Journal for Clinicians 2012 62 1 10 29 2-s2.0-84855792427 10.3322/caac.20138
-
(2012)
CA Cancer Journal for Clinicians
, vol.62
, Issue.1
, pp. 10-29
-
-
Siegel, R.1
Naishadham, D.2
Jemal, A.3
-
2
-
-
80055122337
-
Optimal primary surgical treatment for advanced epithelial ovarian cancer
-
2-s2.0-80055122337
-
Elattar A., Bryant A., Winter-Roach B. A., Hatem M., Naik R., Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database of Systematic Reviews 2011 8 CD007565 2-s2.0-80055122337
-
(2011)
Cochrane Database of Systematic Reviews
, Issue.8
-
-
Elattar, A.1
Bryant, A.2
Winter-Roach, B.A.3
Hatem, M.4
Naik, R.5
-
3
-
-
84856007415
-
Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers
-
2-s2.0-84856007415 10.1038/bjc.2011.455
-
Braicu E.-I., Sehouli J., Richter R., Pietzner K., Denkert C., Fotopoulou C., Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. British Journal of Cancer 2011 105 12 1818 1824 2-s2.0-84856007415 10.1038/bjc.2011.455
-
(2011)
British Journal of Cancer
, vol.105
, Issue.12
, pp. 1818-1824
-
-
Braicu, E.-I.1
Sehouli, J.2
Richter, R.3
Pietzner, K.4
Denkert, C.5
Fotopoulou, C.6
-
4
-
-
37849025830
-
Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: A Gynecologic Oncology Group study
-
2-s2.0-37849025830 10.1200/JCO.2007.13.1953
-
Winter W. E. III, Maxwell G. L., Tian C., Sundborg M. J., Rose G. S., Rose P. G., Rubin S. C., Muggia F., McGuire W. P., Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group study. Journal of Clinical Oncology 2008 26 1 83 89 2-s2.0-37849025830 10.1200/JCO.2007.13.1953
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.1
, pp. 83-89
-
-
Winter III, E.W.1
Maxwell, G.L.2
Tian, C.3
Sundborg, M.J.4
Rose, G.S.5
Rose, P.G.6
Rubin, S.C.7
Muggia, F.8
McGuire, W.P.9
-
5
-
-
79959328816
-
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer - Shifting the paradigm
-
2-s2.0-79959328816 10.1016/j.humpath.2011.03.003
-
Kurman R. J., Shih I.-M., Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Human Pathology 2011 42 7 918 931 2-s2.0-79959328816 10.1016/j.humpath.2011.03.003
-
(2011)
Human Pathology
, vol.42
, Issue.7
, pp. 918-931
-
-
Kurman, R.J.1
Shih, I.-M.2
-
6
-
-
41349100528
-
Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications
-
DOI 10.1097/PGP.0b013e318161e4f5
-
Kurman R. J., Shih I.-M., Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. International Journal of Gynecological Pathology 2008 27 2 151 160 2-s2.0-41349100528 10.1097/PGP.0b013e318161e4f5 (Pubitemid 351450677)
-
(2008)
International Journal of Gynecological Pathology
, vol.27
, Issue.2
, pp. 151-160
-
-
Kurman, R.J.1
Shih, I.-M.2
-
7
-
-
84862003959
-
Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: Cell type is the most useful prognostic factor
-
Bamias A., Sotiropoulou M., Zagouri F., Trachana P., Sakellariou K., Kostouros E., Kakoyianni K., Rodolakis A., Vlahos G., Haidopoulos D., Thomakos N., Antsaklis A., Dimopoulos M. A., Prognostic evaluation of tumour type and other histopathological characteristics in advanced epithelial ovarian cancer, treated with surgery and paclitaxel/carboplatin chemotherapy: cell type is the most useful prognostic factor. European Journal of Cancer 2012 48 1476 1483
-
(2012)
European Journal of Cancer
, vol.48
, pp. 1476-1483
-
-
Bamias, A.1
Sotiropoulou, M.2
Zagouri, F.3
Trachana, P.4
Sakellariou, K.5
Kostouros, E.6
Kakoyianni, K.7
Rodolakis, A.8
Vlahos, G.9
Haidopoulos, D.10
Thomakos, N.11
Antsaklis, A.12
Dimopoulos, M.A.13
-
8
-
-
69349088990
-
Ovarian low-grade and high-grade serous carcinoma: Pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems
-
2-s2.0-69349088990 10.1097/PAP.0b013e3181b4fffa
-
Vang R., Shih I.-M., Kurman R. J., Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Advances in Anatomic Pathology 2009 16 5 267 282 2-s2.0-69349088990 10.1097/PAP.0b013e3181b4fffa
-
(2009)
Advances in Anatomic Pathology
, vol.16
, Issue.5
, pp. 267-282
-
-
Vang, R.1
Shih, I.-M.2
Kurman, R.J.3
-
9
-
-
70349975961
-
Human leukocyte antigen class i expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy
-
2-s2.0-70349975961 10.1038/sj.bjc.6605315
-
Shehata M., Mukherjee A., Deen S., Al-Attar A., Durrant L. G., Chan S., Human leukocyte antigen class i expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy. British Journal of Cancer 2009 101 8 1321 1328 2-s2.0-70349975961 10.1038/sj.bjc.6605315
-
(2009)
British Journal of Cancer
, vol.101
, Issue.8
, pp. 1321-1328
-
-
Shehata, M.1
Mukherjee, A.2
Deen, S.3
Al-Attar, A.4
Durrant, L.G.5
Chan, S.6
-
10
-
-
0034255737
-
HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes
-
DOI 10.1002/1097-0215(20000801)87:3<349::AID-IJC7>3.0.CO;2-O
-
Seliger B., Rongcun Y., Atkins D., Hammers S., Huber C., Storkel S., Kiessling R., HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes. International Journal of Cancer 2000 87 349 359 (Pubitemid 30451645)
-
(2000)
International Journal of Cancer
, vol.87
, Issue.3
, pp. 349-359
-
-
Seliger, B.1
Rongcun, Y.2
Atkins, D.3
Hammers, S.4
Huber, C.5
Storkel, S.6
Kiessling, R.7
-
11
-
-
27944441722
-
Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis
-
DOI 10.1002/ijc.21303
-
Watson N. F. S., Ramage J. M., Madjd Z., Spendlove I., Ellis I. O., Scholefield J. H., Durrant L. G., Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. International Journal of Cancer 2006 118 1 6 10 2-s2.0-27944441722 10.1002/ijc.21303 (Pubitemid 41681574)
-
(2006)
International Journal of Cancer
, vol.118
, Issue.1
, pp. 6-10
-
-
Watson, N.F.S.1
Ramage, J.M.2
Madjd, Z.3
Spendlove, I.4
Ellis, I.O.5
Scholefield, J.H.6
Durrant, L.G.7
-
12
-
-
79960587042
-
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
-
2-s2.0-79960587042 10.1073/pnas.1100354108
-
Gooden M., Lampen M., Jordanova E. S., Leffers N., Trimbos J. B., Van Der Burg S. H., Nijman H., Van Hall T., HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 2011 108 26 10656 10661 2-s2.0-79960587042 10.1073/pnas.1100354108
-
(2011)
Proceedings of the National Academy of Sciences of the United States of America
, vol.108
, Issue.26
, pp. 10656-10661
-
-
Gooden, M.1
Lampen, M.2
Jordanova, E.S.3
Leffers, N.4
Trimbos, J.B.5
Van Der Burg, S.H.6
Nijman, H.7
Van Hall, T.8
-
13
-
-
25444478689
-
Total loss of MHC class I is an independent indicator of good prognosis in breast cancer
-
DOI 10.1002/ijc.21163
-
Madjd Z., Spendlove I., Pinder S. E., Ellis I. O., Durrant L. G., Total loss of MHC class I is an independent indicator of good prognosis in breast cancer. International Journal of Cancer 2005 117 2 248 255 2-s2.0-25444478689 10.1002/ijc.21163 (Pubitemid 41377445)
-
(2005)
International Journal of Cancer
, vol.117
, Issue.2
, pp. 248-255
-
-
Madjd, Z.1
Spendlove, I.2
Pinder, S.E.3
Ellis, I.O.4
Durrant, L.G.5
-
14
-
-
70349866372
-
Correlation of human leukocyte antigen-g (hla-g) expression and disease progression in epithelial ovarian cancer
-
2-s2.0-70349866372 10.1177/1933719109342131
-
Wook Jung Y., Tae Kim Y., Wun Kim S., Kim S., Hoon Kim J., Hoon Cho N., Wook Kim J., Correlation of human leukocyte antigen-g (hla-g) expression and disease progression in epithelial ovarian cancer. Reproductive Sciences 2009 16 11 1103 1111 2-s2.0-70349866372 10.1177/1933719109342131
-
(2009)
Reproductive Sciences
, vol.16
, Issue.11
, pp. 1103-1111
-
-
Wook Jung, Y.1
Tae Kim, Y.2
Wun Kim, S.3
Kim, S.4
Hoon Kim, J.5
Hoon Cho, N.6
Wook Kim, J.7
-
15
-
-
0027981513
-
Medical progress: Renal transplantation
-
2-s2.0-0027981513 10.1056/NEJM199408113310606
-
Suthanthiran M., Strom T. B., Medical progress: renal transplantation. The New England Journal of Medicine 1994 331 6 365 375 2-s2.0-0027981513 10.1056/NEJM199408113310606
-
(1994)
The New England Journal of Medicine
, vol.331
, Issue.6
, pp. 365-375
-
-
Suthanthiran, M.1
Strom, T.B.2
-
16
-
-
34247274772
-
Functions of HLA-G in the immune system
-
DOI 10.1111/j.1399-0039.2006.763-6.x
-
Favier B., LeMaoult J., Carosella E. D., Functions of HLA-G in the immune system. Tissue Antigens 2007 69 1 150 152 2-s2.0-34247274772 10.1111/j.1399-0039.2006.763-6.x (Pubitemid 46625875)
-
(2007)
Tissue Antigens
, vol.69
, Issue.SUPPL. 1
, pp. 150-152
-
-
Favier, B.1
LeMaoult, J.2
Carosella, E.D.3
-
17
-
-
0742322659
-
HLA-G in cancer: A way to turn off the immune system
-
DOI 10.1016/S1044-579X(03)00023-3
-
Rouas-Freiss N., Moreau P., Menier C., Carosella E. D., HLA-G in cancer: a way to turn off the immune system. Seminars in Cancer Biology 2003 13 5 325 336 2-s2.0-0742322659 10.1016/S1044-579X(03)00023-3 (Pubitemid 38160931)
-
(2003)
Seminars in Cancer Biology
, vol.13
, Issue.5
, pp. 325-336
-
-
Rouas-Freiss, N.1
Moreau, P.2
Menier, C.3
Carosella, E.D.4
-
18
-
-
0031911127
-
Differential processing of influenza nucleoprotein in human and mouse cells
-
DOI 10.1002/(SICI)1521-4141(199802)28:02<625::AID-IMMU625>3.0.CO;2- I
-
Braud V. M., McMichael A. J., Cerundolo V., Differential processing of influenza nucleoprotein in human and mouse cells. European Journal of Immunology 1998 28 625 635 (Pubitemid 28101740)
-
(1998)
European Journal of Immunology
, vol.28
, Issue.2
, pp. 625-635
-
-
Braud, V.M.1
McMichael, A.J.2
Cerundolo, V.3
-
19
-
-
0032574781
-
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
-
DOI 10.1073/pnas.95.9.5199
-
Lee N., Llano M., Carretero M., Akiko-Ishitani A.-I., Navarro F., López-Botet M., Geraghty D. E., HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 5199 5204 2-s2.0-0032574781 10.1073/pnas.95.9.5199 (Pubitemid 28208575)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.9
, pp. 5199-5204
-
-
Lee, N.1
Llano, M.2
Carretero, M.3
Akiko-Ishitani, A.I.4
Navarro, F.5
Lopez-Botet, M.6
Geraghty, D.E.7
-
20
-
-
0034117882
-
Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis
-
DOI 10.1016/S0167-5699(00)01596-6, PII S0167569900015966
-
Moretta A., Biassoni R., Bottino C., Mingari M. C., Moretta L., Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. Immunology Today 2000 21 5 228 234 2-s2.0-0034117882 10.1016/S0167-5699(00)01596-6 (Pubitemid 30259028)
-
(2000)
Immunology Today
, vol.21
, Issue.5
, pp. 228-234
-
-
Moretta, A.1
Biassoni, R.2
Bottino, C.3
Mingari, M.C.4
Moretta, L.5
-
21
-
-
0036855636
-
IFN-γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism
-
DOI 10.1172/JCI200215564
-
Malmberg K.-J., Levitsky V., Norell H., De Matos C. T., Carlsten M., Schedvins K., Rabbani H., Moretta A., Söderström K., Levitskaya J., Kiessling R., IFN- γ protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism. Journal of Clinical Investigation 2002 110 10 1515 1523 2-s2.0-0036855636 10.1172/JCI200215564 (Pubitemid 35396922)
-
(2002)
Journal of Clinical Investigation
, vol.110
, Issue.10
, pp. 1515-1523
-
-
Malmberg, K.-J.1
Levitsky, V.2
Norell, H.3
De Matos, C.T.4
Carlsten, M.5
Schedvins, K.6
Rabbani, H.7
Moretta, A.8
Soderstrom, K.9
Levitskaya, J.10
Kiessling, R.11
-
22
-
-
38449107523
-
HLA-G expression in human ovarian carcinoma counteracts NK cell function
-
2-s2.0-38449107523 10.1093/annonc/mdm356
-
Lin A., Yan W.-H., Xu H.-H., Gan M.-F., Cai J.-F., Zhu M., Zhou M.-Y., HLA-G expression in human ovarian carcinoma counteracts NK cell function. Annals of Oncology 2007 18 11 1804 1809 2-s2.0-38449107523 10.1093/annonc/mdm356
-
(2007)
Annals of Oncology
, vol.18
, Issue.11
, pp. 1804-1809
-
-
Lin, A.1
Yan, W.-H.2
Xu, H.-H.3
Gan, M.-F.4
Cai, J.-F.5
Zhu, M.6
Zhou, M.-Y.7
-
23
-
-
0032788734
-
HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
-
DOI 10.1093/intimm/11.8.1351
-
Le Gal F.-A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., Guillet J.-G., Carosella E. D., Rouas-Freiss N., HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. International Immunology 1999 11 8 1351 1356 2-s2.0-0032788734 10.1093/intimm/11.8.1351 (Pubitemid 29355674)
-
(1999)
International Immunology
, vol.11
, Issue.8
, pp. 1351-1356
-
-
Le Gal, F.-A.1
Riteau, B.2
Sedlik, C.3
Khalil-Daher, I.4
Menier, C.5
Dausset, J.6
Guillet, J.-G.7
Carosella, E.D.8
Rouas-Freiss, N.9
-
24
-
-
0037261143
-
+ cells and inhibit cytotoxic T cell activity through CD8 ligation
-
DOI 10.1002/immu.200390015
-
Contini P., Ghio M., Poggi A., Filaci G., Indiveri F., Ferrone S., Puppo F., Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. European Journal of Immunology 2003 33 1 125 134 2-s2.0-0037261143 10.1002/immu.200390015 (Pubitemid 36157650)
-
(2003)
European Journal of Immunology
, vol.33
, Issue.1
, pp. 125-134
-
-
Contini, P.1
Ghio, M.2
Poggi, A.3
Filaci, G.4
Indiveri, F.5
Ferrone, S.6
Puppo, F.7
-
25
-
-
34250777115
-
Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer
-
DOI 10.1158/1078-0432.CCR-06-2087
-
Rolland P., Deen S., Scott I., Durrant L., Spendlove I., Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer. Clinical Cancer Research 2007 13 12 3591 3596 2-s2.0-34250777115 10.1158/1078-0432.CCR-06-2087 (Pubitemid 46955120)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.12
, pp. 3591-3596
-
-
Rolland, P.1
Deen, S.2
Scott, I.3
Durrant, L.4
Spendlove, I.5
-
26
-
-
50349084447
-
HLA class i antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma
-
2-s2.0-50349084447 10.1158/1078-0432.CCR-07-4433
-
Han L., Fletcher M. S., Urbauer D. L., Mueller P., Landen C. N., Kamat A. A., Lin Y. G., Merritt W. M., Spannuth W. A., Deavers M. T., De Geest K., Gershenson D. M., Lutgendorf S. K., Ferrone S., Sood A. K., HLA class i antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma. Clinical Cancer Research 2008 14 11 3372 3379 2-s2.0-50349084447 10.1158/1078-0432.CCR-07-4433
-
(2008)
Clinical Cancer Research
, vol.14
, Issue.11
, pp. 3372-3379
-
-
Han, L.1
Fletcher, M.S.2
Urbauer, D.L.3
Mueller, P.4
Landen, C.N.5
Kamat, A.A.6
Lin, Y.G.7
Merritt, W.M.8
Spannuth, W.A.9
Deavers, M.T.10
De Geest, K.11
Gershenson, D.M.12
Lutgendorf, S.K.13
Ferrone, S.14
Sood, A.K.15
-
27
-
-
0032927788
-
Expression of HLA G in human tumors is not a frequent event
-
DOI 10.1002/(SICI)1097-0215(19990517)81:4<512::AID-IJC2>3.0.CO;2-O
-
Real L. M., Cabrera T., Collado A., Jimenez P., Garcia A., Ruiz-Cabello F., Garrido F., Expression of HLA G in human tumors is not a frequent event. International Journal of Cancer 1999 81 512 518 (Pubitemid 29203045)
-
(1999)
International Journal of Cancer
, vol.81
, Issue.4
, pp. 512-518
-
-
Real, L.M.1
Cabrera, T.2
Collado, A.3
Jimenez, P.4
Garcia, A.5
Ruiz-Cabello, F.6
Garrido, F.7
-
28
-
-
0034850150
-
Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production
-
Urosevic M., Kurrer M. O., Kamarashev J., Mueller B., Weder W., Burg G., Stahel R. A., Dummer R., Trojan A., Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. The American Journal of Pathology 2001 159 3 817 824 2-s2.0-0034850150 (Pubitemid 32847172)
-
(2001)
American Journal of Pathology
, vol.159
, Issue.3
, pp. 817-824
-
-
Urosevic, M.1
Kurrer, M.O.2
Kamarashev, J.3
Mueller, B.4
Weder, W.5
Burg, G.6
Stahel, R.A.7
Dummer, R.8
Trojan, A.9
-
29
-
-
0036184227
-
Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer
-
DOI 10.1002/path.1039
-
Lefebvre S., Antoine M., Uzan S., McMaster M., Dausset J., Carosella E. D., Paul P., Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. Journal of Pathology 2002 196 3 266 274 2-s2.0-0036184227 10.1002/path.1039 (Pubitemid 34189414)
-
(2002)
Journal of Pathology
, vol.196
, Issue.3
, pp. 266-274
-
-
Lefebvre, S.1
Antoine, M.2
Uzan, S.3
McMaster, M.4
Dausset, J.5
Carosella, E.D.6
Paul, P.7
-
30
-
-
24344475645
-
Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis
-
DOI 10.1002/ijc.21151
-
Rouas-Freiss N., Bruel S., Menier C., Marcou C., Moreau P., Carosella E. D., Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis. International Journal of Cancer 2005 117 1 114 122 2-s2.0-24344475645 10.1002/ijc.21151 (Pubitemid 41262765)
-
(2005)
International Journal of Cancer
, vol.117
, Issue.1
, pp. 114-122
-
-
Rouas-Freiss, N.1
Bruel, S.2
Menier, C.3
Marcou, C.4
Moreau, P.5
Carosella, E.D.6
-
31
-
-
10044255346
-
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma
-
DOI 10.1016/j.ygyno.2004.09.049, PII S0090825804008005
-
Davidson B., Elstrand M. B., McMaster M. T., Berner A., Kurman R. J., Risberg B., Trope C. G., Shih I.-M., HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma. Gynecologic Oncology 2005 96 1 42 47 2-s2.0-10044255346 10.1016/j.ygyno.2004.09. 049 (Pubitemid 39612415)
-
(2005)
Gynecologic Oncology
, vol.96
, Issue.1
, pp. 42-47
-
-
Davidson, B.1
Elstrand, M.B.2
McMaster, M.T.3
Berner, A.4
Kurman, R.J.5
Risberg, B.6
Trope, C.G.7
Shih, I.-M.8
-
32
-
-
35748943909
-
Expression of HLA-G in cancer bladder
-
2-s2.0-35748943909
-
El-Chennawi F. A., Auf F. A., El-Diasty A. M., El-Daim M. A., El-Sherbiny S. M., Ali A., El-Baz M., El-Hameed M. A., Paul P., Ibrahim E.-C., Carosella E., Ghoneim M. A., Expression of HLA-G in cancer bladder. The Egyptian Journal of Immunology 2005 12 1 57 64 2-s2.0-35748943909
-
(2005)
The Egyptian Journal of Immunology
, vol.12
, Issue.1
, pp. 57-64
-
-
El-Chennawi, F.A.1
Auf, F.A.2
El-Diasty, A.M.3
El-Daim, M.A.4
El-Sherbiny, S.M.5
Ali, A.6
El-Baz, M.7
El-Hameed, M.A.8
Paul, P.9
Ibrahim, E.-C.10
Carosella, E.11
Ghoneim, M.A.12
-
33
-
-
0242671571
-
HLA-G and IL-10 expression in human cancer - Different stories with the same message
-
DOI 10.1016/S1044-579X(03)00024-5
-
Urosevic M., Dummer R., HLA-G and IL-10 expression in human cancer-different stories with the same message. Seminars in Cancer Biology 2003 13 5 337 342 2-s2.0-0242671571 10.1016/S1044-579X(03)00024-5 (Pubitemid 38160932)
-
(2003)
Seminars in Cancer Biology
, vol.13
, Issue.5
, pp. 337-342
-
-
Urosevic, M.1
Dummer, R.2
-
34
-
-
79959846349
-
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
-
2-s2.0-79959846349 10.1182/blood-2010-07-294389
-
Agaugué S., Carosella E. D., Rouas-Freiss N., Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17. Blood 2011 117 26 7021 7031 2-s2.0-79959846349 10.1182/blood-2010-07-294389
-
(2011)
Blood
, vol.117
, Issue.26
, pp. 7021-7031
-
-
Agaugué, S.1
Carosella, E.D.2
Rouas-Freiss, N.3
-
35
-
-
84862122547
-
The role of classical and non-classical HLA class i antigens in human tumors
-
Bukur J., Jasinski S., Seliger B., The role of classical and non-classical HLA class I antigens in human tumors. Seminars in Cancer Biology 2012 22 350 358
-
(2012)
Seminars in Cancer Biology
, vol.22
, pp. 350-358
-
-
Bukur, J.1
Jasinski, S.2
Seliger, B.3
-
36
-
-
84879796288
-
Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy
-
Gluck S., de S. F., Peeters J., Stork-Sloots L., Somlo G., Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy. Breast Cancer Research and Treatment 2013 139 759 767
-
(2013)
Breast Cancer Research and Treatment
, vol.139
, pp. 759-767
-
-
Gluck, S.1
De, S.F.2
Peeters, J.3
Stork-Sloots, L.4
Somlo, G.5
-
37
-
-
70449529629
-
Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology
-
2-s2.0-70449529629 10.1016/j.humimm.2009.07.021
-
Menier C., Prevot S., Carosella E. D., Rouas-Freiss N., Human leukocyte antigen-G is expressed in advanced-stage ovarian carcinoma of high-grade histology. Human Immunology 2009 70 12 1006 1009 2-s2.0-70449529629 10.1016/j.humimm.2009.07.021
-
(2009)
Human Immunology
, vol.70
, Issue.12
, pp. 1006-1009
-
-
Menier, C.1
Prevot, S.2
Carosella, E.D.3
Rouas-Freiss, N.4
-
38
-
-
4644225190
-
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
-
DOI 10.1016/j.ygyno.2004.07.011, PII S0090825804005232
-
Gordon A. N., Tonda M., Sun S., Rackoff W., Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer. Gynecologic Oncology 2004 95 1 1 8 2-s2.0-4644225190 10.1016/j.ygyno.2004.07.011 (Pubitemid 39286270)
-
(2004)
Gynecologic Oncology
, vol.95
, Issue.1
, pp. 1-8
-
-
Gordon, A.N.1
Tonda, M.2
Sun, S.3
Rackoff, W.4
-
39
-
-
84875424539
-
Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma
-
Rauh-Hain J. A., Nitschmann C. C., Worley J., Bradford L. S., Berkowitz R. S., Schorge J. O., Campos S. M., del Carmen M. G., Horowitz N. S., Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecologic Oncology 2013 129 63 68
-
(2013)
Gynecologic Oncology
, vol.129
, pp. 63-68
-
-
Rauh-Hain, J.A.1
Nitschmann, C.C.2
Worley, J.3
Bradford, L.S.4
Berkowitz, R.S.5
Schorge, J.O.6
Campos, S.M.7
Del Carmen, M.G.8
Horowitz, N.S.9
-
40
-
-
11344290086
-
HLA class I antigen down-regulation in primary ovary carcinoma lesions: Association with disease stage
-
Vitale M., Pelusi G., Taroni B., Gobbi G., Micheloni C., Rezzani R., Donato F., Wang X., Ferrone S., HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage. Clinical Cancer Research 2005 11 1 67 72 2-s2.0-11344290086 (Pubitemid 40075779)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.1
, pp. 67-72
-
-
Vitale, M.1
Pelusi, G.2
Taroni, B.3
Gobbi, G.4
Micheloni, C.5
Rezzani, R.6
Donato, F.7
Wang, X.8
Ferrone, S.9
-
41
-
-
0034788243
-
MHC antigens and tumor escape from immune surveillance
-
DOI 10.1016/S0065-230X(01)83005-0
-
Garrido F., Algarra I., MHC antigens and tumor escape from immune surveillance. Advances in Cancer Research 2001 83 117 158 2-s2.0-0034788243 10.1016/S0065-230X(01)83005-0 (Pubitemid 32959264)
-
(2001)
Advances in Cancer Research
, vol.83
, pp. 117-158
-
-
Garrido, F.1
Algarra, I.2
-
42
-
-
78650666422
-
HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients
-
2-s2.0-78650666422 10.4049/jimmunol.1002629
-
De Kruijf E. M., Sajet A., Van Nes J. G. H., Natanov R., Putter H., Smit V. T. H. B. M., Liefers G. J., Van Den Elsen P. J., Van De Velde C. J. H., Kuppen P. J. K., HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. Journal of Immunology 2010 185 12 7452 7459 2-s2.0-78650666422 10.4049/jimmunol.1002629
-
(2010)
Journal of Immunology
, vol.185
, Issue.12
, pp. 7452-7459
-
-
De Kruijf, E.M.1
Sajet, A.2
Van Nes, J.G.H.3
Natanov, R.4
Putter, H.5
Smit, V.T.H.B.M.6
Liefers, G.J.7
Van Den Elsen, P.J.8
Van De Velde, C.J.H.9
Kuppen, P.J.K.10
-
43
-
-
84892928492
-
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
-
10.1038/bjc.2013.696
-
Zeestraten E. C., Reimers M. S., Saadatmand S., Dekker J. W., Liefers G. J., van den Elsen P. J., van de Velde C. J., Kuppen P. J., Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. British Journal of Cancer 2013 110 459 468 10.1038/bjc.2013.696
-
(2013)
British Journal of Cancer
, vol.110
, pp. 459-468
-
-
Zeestraten, E.C.1
Reimers, M.S.2
Saadatmand, S.3
Dekker, J.W.4
Liefers, G.J.5
Van Den Elsen, P.J.6
Van De Velde, C.J.7
Kuppen, P.J.8
-
44
-
-
10744230955
-
HLA-G is a potential tumor marker in malignant ascites
-
Singer G., Rebmann V., Chen Y.-C., Liu H.-T., Ali S. Z., Reinsberg J., McMaster M. T., Pfeiffer K., Chan D. W., Wardelmann E., Grosse-Wilde H., Cheng C.-C., Kurman R. J., Shih I.-M., HLA-G is a potential tumor marker in malignant ascites. Clinical Cancer Research 2003 9 12 4460 4464 2-s2.0-10744230955 (Pubitemid 37248404)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.12
, pp. 4460-4464
-
-
Singer, G.1
Rebmann, V.2
Chen, Y.-C.3
Liu, H.-T.4
Ali, S.Z.5
Reinsberg, J.6
McMaster, M.T.7
Pfeiffer, K.8
Chan, D.W.9
Wardelmann, E.10
Grosse-Wilde, H.11
Cheng, C.-C.12
Kurman, R.J.13
Shih, I.-M.14
-
45
-
-
1942469352
-
Ovarian tumorigenesis: A proposed model based on morphological and molecular genetic analysis
-
Shih I.-M., Kurman R. J., Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. The American Journal of Pathology 2004 164 5 1511 1518 2-s2.0-1942469352 (Pubitemid 38529752)
-
(2004)
American Journal of Pathology
, vol.164
, Issue.5
, pp. 1511-1518
-
-
Shih, I.-M.1
Kurman, R.J.2
-
46
-
-
84874221814
-
KIR2DL4 (CD158d): An activation receptor for HLA-G
-
Rajagopalan S., Long E. O., KIR2DL4 (CD158d): an activation receptor for HLA-G. Frontiers in Immunology 2012 3 258
-
(2012)
Frontiers in Immunology
, vol.3
, pp. 258
-
-
Rajagopalan, S.1
Long, E.O.2
-
47
-
-
84875061936
-
Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression
-
Lin A., Xu H. H., Xu D. P., Zhang X., Wang Q., Yan W. H., Multiple steps of HLA-G in ovarian carcinoma metastasis: alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression. Human Immunology 2013 74 439 446
-
(2013)
Human Immunology
, vol.74
, pp. 439-446
-
-
Lin, A.1
Xu, H.H.2
Xu, D.P.3
Zhang, X.4
Wang, Q.5
Yan, W.H.6
-
48
-
-
33947589232
-
Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation
-
DOI 10.1182/blood-2006-06-030213
-
Coupel S., Moreau A., Hamidou M., Horejsi V., Soulillou J.-P., Charreau B., Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 2007 109 7 2806 2814 2-s2.0-33947589232 10.1182/blood-2006-06-030213 (Pubitemid 46482075)
-
(2007)
Blood
, vol.109
, Issue.7
, pp. 2806-2814
-
-
Coupel, S.1
Moreau, A.2
Hamidou, M.3
Horejsi, V.4
Soulillou, J.-P.5
Charreau, B.6
-
49
-
-
46749123555
-
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
-
2-s2.0-46749123555 10.1182/blood-2007-12-127662
-
Carosella E. D., Favier B., Rouas-Freiss N., Moreau P., Lemaoult J., Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 2008 111 10 4862 4870 2-s2.0-46749123555 10.1182/blood-2007-12-127662
-
(2008)
Blood
, vol.111
, Issue.10
, pp. 4862-4870
-
-
Carosella, E.D.1
Favier, B.2
Rouas-Freiss, N.3
Moreau, P.4
Lemaoult, J.5
-
50
-
-
33846366392
-
Potential predictors of chemotherapy response in ovarian cancer-How do we define chemosensitivity?
-
DOI 10.1016/j.ygyno.2006.08.039, PII S0090825806006937
-
O'Toole S. A., Sheppard B. L., Laios A., O'Leary J. J., McGuinness E. P. J., D'Arcy T., Bonnar J., Potential predictors of chemotherapy response in ovarian cancer-How do we define chemosensitivity? Gynecologic Oncology 2007 104 2 345 351 2-s2.0-33846366392 10.1016/j.ygyno.2006.08.039 (Pubitemid 46135658)
-
(2007)
Gynecologic Oncology
, vol.104
, Issue.2
, pp. 345-351
-
-
O'Toole, S.A.1
Sheppard, B.L.2
Laios, A.3
O'Leary, J.J.4
McGuinness, E.P.J.5
D'Arcy, T.6
Bonnar, J.7
-
51
-
-
77951938715
-
Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class i molecules in lung cancer patients
-
2-s2.0-77951938715 10.1016/j.humimm.2010.02.015
-
Schütt P., Schütt B., Switala M., Bauer S., Stamatis G., Opalka B., Eberhardt W., Schuler M., Horn P. A., Rebmann V., Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients. Human Immunology 2010 71 5 489 495 2-s2.0-77951938715 10.1016/j.humimm.2010.02.015
-
(2010)
Human Immunology
, vol.71
, Issue.5
, pp. 489-495
-
-
Schütt, P.1
Schütt, B.2
Switala, M.3
Bauer, S.4
Stamatis, G.5
Opalka, B.6
Eberhardt, W.7
Schuler, M.8
Horn, P.A.9
Rebmann, V.10
-
52
-
-
77952091664
-
HLA-G expression in human breast cancer: Implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro
-
2-s2.0-77952091664 10.1245/s10434-009-0891-9
-
He X., Dong D.-D., Yie S.-M., Yang H., Cao M., Ye S.-R., Li K., Liu J., Chen J., HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Annals of Surgical Oncology 2010 17 5 1459 1469 2-s2.0-77952091664 10.1245/s10434-009-0891-9
-
(2010)
Annals of Surgical Oncology
, vol.17
, Issue.5
, pp. 1459-1469
-
-
He, X.1
Dong, D.-D.2
Yie, S.-M.3
Yang, H.4
Cao, M.5
Ye, S.-R.6
Li, K.7
Liu, J.8
Chen, J.9
-
53
-
-
68249127418
-
Characterization of HLA-G expression in renal cell carcinoma
-
2-s2.0-68249127418 10.1111/j.1399-0039.2009.01302.x
-
Li B.-L., Lin A., Zhang X.-J., Zhang X., Zhang J.-G., Wang Q., Zhou W.-J., Chen H.-X., Wang T.-J., Yan W.-H., Characterization of HLA-G expression in renal cell carcinoma. Tissue Antigens 2009 74 3 213 221 2-s2.0-68249127418 10.1111/j.1399-0039.2009.01302.x
-
(2009)
Tissue Antigens
, vol.74
, Issue.3
, pp. 213-221
-
-
Li, B.-L.1
Lin, A.2
Zhang, X.-J.3
Zhang, X.4
Zhang, J.-G.5
Wang, Q.6
Zhou, W.-J.7
Chen, H.-X.8
Wang, T.-J.9
Yan, W.-H.10
-
54
-
-
79960896620
-
Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma
-
2-s2.0-79960896620 10.1002/ijc.25807
-
Lin A., Zhang X., Zhou W.-J., Ruan Y.-Y., Xu D.-P., Wang Q., Yan W.-H., Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma. International Journal of Cancer 2011 129 6 1382 1390 2-s2.0-79960896620 10.1002/ijc.25807
-
(2011)
International Journal of Cancer
, vol.129
, Issue.6
, pp. 1382-1390
-
-
Lin, A.1
Zhang, X.2
Zhou, W.-J.3
Ruan, Y.-Y.4
Xu, D.-P.5
Wang, Q.6
Yan, W.-H.7
|